Showing results (671-680 of 861) with videos related to

Sort By:
Pageof 87
Lupus Science & Medicine|November 8, 2023
Immune complex-driven neutrophil activation and BAFF release: a link to B cell responses in SLETing Wang, Andrew Vasconcellos, John Marken, et al.
Lupus Science & Medicine|September 11, 2023
Systemic Lupus Erythematosus Risk Probability Index: ready for routine use? Results from a Chinese cohortLin Zhang, Wentian Lu, Dong Yan, et al.
Lupus Science & Medicine|August 9, 2023
Vitamin D level in patients with systemic lupus erythematosus: its relationship to disease course and bone mineral densitySergii Shevchuk, Liubov Marynych, Tetiana Malovana, et al.
Lupus Science & Medicine|August 16, 2023
Abnormally high expression of D1-like dopamine receptors on lupus CD4+ T cells promotes Tfh cell differentiationFengxi Wu, Zhongyuan Xiang, Zhenghao He, et al.
Lupus Science & Medicine|October 16, 2023
B cell polygenic risk scores associate with anti-dsDNA antibodies and nephritis in systemic lupus erythematosusAnna Hedenstedt, Sarah Reid, Ahmed Sayadi, et al.
Lupus Science & Medicine|October 19, 2023
Identification and assessment of classification criteria attributes for systemic lupus erythematosus in a regional medical record data networkNoah Forrest, Kathryn L Jackson, Steven Tran, et al.
Lupus Science & Medicine|October 18, 2023
Association of patient copayment and medication adherence in systemic lupus erythematosusRaisa Lomanto Silva, Gretchen M Swabe, Sebastian Eduardo Sattui, et al.
Lupus Science & Medicine|October 25, 2023
Mononuclear cells from patients with rhupus are influenced by TNF in their production of gp130/sIL-6Rb and APRILLuis M Amezcua-Guerra, Fausto Sánchez-Muñoz, Santiago Guzmán-García, et al.
Lupus Science & Medicine|October 25, 2023
Microvascular C5b-9 deposition in non-lesional skin in patients with SLE and its correlation with active lupus nephritis: a prospective observational studyMeghan Anderson, Cynthia Magro, H Michael Belmont
Lupus Science & Medicine|October 5, 2023
Selection of indicators reporting response rate in pharmaceutical trials for systemic lupus erythematosus: preference and relative sensitivityJingru Tian, Shuntong Kang, Dingyao Zhang, et al.
Pageof 87